Yijia Pan

1.0k total citations
30 papers, 727 citations indexed

About

Yijia Pan is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yijia Pan has authored 30 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Yijia Pan's work include CAR-T cell therapy research (18 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (5 papers). Yijia Pan is often cited by papers focused on CAR-T cell therapy research (18 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (5 papers). Yijia Pan collaborates with scholars based in United States, China and Sweden. Yijia Pan's co-authors include Yingxiao Wang, Shu Chien, Yiqian Wu, Ziliang Huang, Ya‐Ju Chang, M. M. Allen, Xin Wang, Sangpil Yoon, Shaoying Lu and Michel Sadelain and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Yijia Pan

27 papers receiving 721 citations

Peers

Yijia Pan

ONCOL

IMMUN

GENET

Farlan Veraitch United Kingdom

Shirley Mao United States

Douglas Houghton Campbell Australia

Brian Armstrong United States

Achuthamangalam B. Madhankumar United States

Praju Vikas Anekal United States

Min-Joon Han United States

Alexis J. Torres United States

Alexander L. Watters United States

Sabrina C. Desbordes United States

Farlan Veraitch United Kingdom

Yijia Pan

467 ×1.4

290 ×1.0

ONCOL

486 ×1.8

96 ×0.7

IMMUN

103 ×1.2

GENET

Citations per year, relative to Yijia Pan Yijia Pan (= 1×) peers Farlan Veraitch

Countries citing papers authored by Yijia Pan

Since Specialization

Citations

This map shows the geographic impact of Yijia Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yijia Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yijia Pan more than expected).

Fields of papers citing papers by Yijia Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yijia Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yijia Pan. The network helps show where Yijia Pan may publish in the future.

Co-authorship network of co-authors of Yijia Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Yijia Pan. A scholar is included among the top collaborators of Yijia Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yijia Pan. Yijia Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pan, Yijia, Yumeng Zhang, Hao Lu, et al.. (2025). Molecular dynamics of immortalized chicken fibroblasts from adherent cultivation to carrier-free suspension culture. Food Bioscience. 73. 107716–107716.

Lu, Dan, Soohyung Park, Mark B. Landon, et al.. (2025). A novel CD3ε fusion receptor allows T cell engager use in TCR-less allogeneic CAR T cells to improve activity and prevent antigen escape. Molecular Therapy. 33(9). 4570–4583.

Hancock, Bryan, Brian Groff, Yijia Pan, et al.. (2024). Abstract 3618: High-avidity BCMA CAR and high-affinity, non-cleavable CD16 Fc receptor incorporated in off-the-shelf CAR T cells promote multi-antigen targeting and durable anti-tumor cytotoxicity in the treatment of multiple myeloma. Cancer Research. 84(6_Supplement). 3618–3618. 1 indexed citations

Hammer, Quirin, Karlo Perica, Rina M. Mbofung, et al.. (2024). Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies. Cell stem cell. 31(9). 1376–1386.e8. 18 indexed citations

Pan, Yijia, Linda Shi, Chi Woo Yoon, et al.. (2022). Mechanosensor Piezo1 mediates bimodal patterns of intracellular calcium and FAK signaling. The EMBO Journal. 41(17). e111799–e111799. 23 indexed citations

Yoon, Chi Woo, Yijia Pan, & Yingxiao Wang. (2022). The application of mechanobiotechnology for immuno-engineering and cancer immunotherapy. Frontiers in Cell and Developmental Biology. 10. 1064484–1064484. 8 indexed citations

Drake, Charles G., Alex Garcia, Chia‐Wei Chang, et al.. (2022). 326 Off-the-shelf iPSC-derived CAR-T cells targeting KLK2 demonstrate prolonged tumor control and survival in xenograft models of prostate cancer. Regular and Young Investigator Award Abstracts. A343–A343. 2 indexed citations

Hammer, Quirin, Karlo Perica, Rina M. Mbofung, et al.. (2022). Combined Genetic Ablation of CD54 and CD58 in CAR Engineered Cytotoxic Lymphocytes Effectively Averts Allogeneic Immune Cell Rejection. Blood. 140(Supplement 1). 1165–1166. 5 indexed citations

Wu, Yiqian, Yahan Liu, Ziliang Huang, et al.. (2021). Control of the activity of CAR-T cells within tumours via focused ultrasound. Nature Biomedical Engineering. 5(11). 1336–1347. 161 indexed citations

10.

Mahmood, Sajid, Yijia Pan, Bryan Hancock, et al.. (2021). Dual Chimeric Antigen Receptor Approach Combining Novel Tumor Targeting Strategies Circumvents Antigen Escape in Multiple Myeloma. Blood. 138(Supplement 1). 1718–1718. 9 indexed citations

11.

Mbofung, Rina M., Yijia Pan, Brian Groff, et al.. (2021). Off-the-Shelf, iPSC-Derived CAR-NK Cells Multiplexed-Engineered for the Avoidance of Allogeneic Host Immune Cell Rejection. Blood. 138(Supplement 1). 2795–2795. 2 indexed citations

12.

Pan, Yijia, Brian Groff, Rina M. Mbofung, et al.. (2021). A Novel Stealth Strategy That Activates Adoptively Transferred Allogeneic Immune Cells and Avoids Rejection for Off-the-Shelf Cell-Based Cancer Therapy. Blood. 138(Supplement 1). 4800–4800. 1 indexed citations

13.

Yoon, Sangpil, Yijia Pan, K. Kirk Shung, & Yingxiao Wang. (2020). FRET-Based Ca2+ Biosensor Single Cell Imaging Interrogated by High-Frequency Ultrasound. Sensors. 20(17). 4998–4998. 9 indexed citations

14.

Huang, Ziliang, Yiqian Wu, Yijia Pan, et al.. (2020). Engineering light-controllable CAR T cells for cancer immunotherapy. Science Advances. 6(8). eaay9209–eaay9209. 129 indexed citations

15.

Zhang, Chengwei, Qiao Li, Fang Wang, et al.. (2020). Relationship between the site of thrombosis and the prevalence of pulmonary embolism in acute lower extremity deep venous thrombosis. Journal of Vascular Surgery Venous and Lymphatic Disorders. 8(5). 725–733. 7 indexed citations

16.

Bjordahl, Ryan, John Goulding, Mochtar Pribadi, et al.. (2020). Development of a Novel MICA/B-Specific CAR As a Pan-Tumor Targeting Strategy for Off-the-Shelf, Cell-Based Cancer Immunotherapy. Blood. 136(Supplement 1). 5–6. 2 indexed citations

17.

Zhou, Wei, Phillip Kyriakakis, Yiqian Wu, et al.. (2019). An AND-Gated Drug and Photoactivatable Cre-loxP System for Spatiotemporal Control in Cell-Based Therapeutics. ACS Synthetic Biology. 8(10). 2359–2371. 27 indexed citations

18.

Pan, Yijia, Shaoying Lu, Lei Lei, et al.. (2019). Genetically Encoded FRET Biosensor for Visualizing EphA4 Activity in Different Compartments of the Plasma Membrane. ACS Sensors. 4(2). 294–300. 12 indexed citations

19.

Pan, Yijia, Sangpil Yoon, Jie Sun, et al.. (2018). Mechanogenetics for the remote and noninvasive control of cancer immunotherapy. Proceedings of the National Academy of Sciences. 115(5). 992–997. 207 indexed citations

20.

Qin, Peng, Shaoying Lu, Yuxin Shi, et al.. (2018). Coordinated histone modifications and chromatin reorganization in a single cell revealed by FRET biosensors. Proceedings of the National Academy of Sciences. 115(50). E11681–E11690. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact